News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,921 Results
Type
Article (2723)
Company Profile (28)
Press Release (39169)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (16027)
Career Advice (78)
Deals (2155)
Drug Delivery (12)
Drug Development (4203)
Employer Resources (10)
FDA (456)
Job Trends (792)
News (20405)
Policy (1052)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
2027 Genetown Digital (1)
2027 NextGen (2)
2027 Pharm Country Digital (1)
Academia (147)
Accelerated approval (1)
ADA (4)
Allergies (8)
Alliances (3484)
ALS (10)
Alzheimer's disease (79)
Antibody-drug conjugate (ADC) (63)
Approvals (475)
Artificial intelligence (64)
ASCO (16)
Autoimmune disease (43)
Automation (6)
Bankruptcy (13)
Belgium (1)
Best Places to Work (476)
BIO (12)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (27)
BioSpace Insights (14)
Biotechnology (17)
Bispecific (3)
Bladder cancer (11)
Brain cancer (9)
Breast cancer (65)
Cancer (506)
Cardiovascular disease (19)
Career advice (68)
Career pathing (1)
CAR-T (57)
CDC (2)
CDMO (10)
Celiac Disease (1)
Cell therapy (123)
Cervical cancer (9)
Clinical research (3710)
Collaboration (284)
Commercialization (3)
Company closure (4)
Compensation (163)
Complete response letters (1)
COVID-19 (188)
CRISPR (16)
CRO (1)
C-suite (215)
Cystic fibrosis (8)
Data (720)
Denatured (6)
Depression (12)
Dermatology (3)
Diabetes (26)
Diagnostics (522)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (63)
Drug pricing (10)
Duchenne muscular dystrophy (66)
Earnings (4808)
Editorial (6)
Employer branding (1)
Employer resources (8)
ESMO (28)
Events (6795)
Executive appointments (173)
FDA (680)
Fragile X (1)
Friedreich's ataxia (9)
Frontotemporal dementia (1)
Funding (257)
Gene editing (47)
Generative AI (3)
Gene therapy (88)
GLP-1 (84)
Government (165)
Guidances (26)
Healthcare (733)
Hematology (10)
HIV (4)
Huntington's disease (6)
IgA nephropathy (18)
Immunology and inflammation (45)
Immuno-oncology (28)
Indications (13)
Infectious disease (213)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (47)
Interviews (7)
IPO (1008)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (4)
Kidney cancer (15)
Kidney disease (9)
Labor market (14)
Layoffs (57)
Leadership (4)
Legal (213)
Licensing (9)
Liver cancer (8)
Longevity (7)
Lung cancer (49)
Lung diease (3)
Lymphoma (21)
Machine learning (5)
Management (4)
Manufacturing (100)
MASH (19)
Medical device (318)
Medtech (324)
Mergers & acquisitions (1286)
Metabolic disorders (111)
Middle East (1)
mRNA (20)
Multiple sclerosis (30)
Multispecific (1)
Netherlands (1)
Neurodegenerative disease (46)
Neuropsychiatric disorders (14)
Neuroscience (236)
NextGen: Class of 2026 (355)
Non-profit (159)
Now hiring (18)
Obesity (55)
Opinion (21)
Ovarian cancer (35)
Pain (44)
Pancreatic cancer (29)
Parkinson's disease (17)
Partnered (4)
Patents (78)
Patient recruitment (66)
Patient selection (11)
Peanut (1)
People (6135)
Pharmaceutical (2)
Phase 1 (1587)
Phase 2 (1822)
Phase 3 (987)
Pipeline (987)
Policy (18)
Postmarket research (30)
Preclinical (680)
Press Release (3)
Prostate cancer (10)
Psychedelics (6)
Radioligand (1)
Radiopharmaceuticals (24)
Rare diseases (120)
Real estate (425)
Recruiting (5)
Regenerative medicine (1)
Regulatory (1034)
Reports (7)
Research institute (151)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (7)
RSV (3)
Saudi Arabia (1)
Schizophrenia (18)
Series A (64)
Series B (30)
Sickle cell disease (4)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (507)
Stomach cancer (4)
Supply chain (6)
Tariffs (2)
The Weekly (11)
Vaccines (77)
Venture capital (25)
Weight loss (32)
Women's health (32)
Women in leadership (1)
Worklife (2)
Date
Today (15)
Last 7 days (74)
Last 30 days (255)
Last 365 days (2473)
2026 (2106)
2025 (2442)
2024 (2591)
2023 (2870)
2022 (3762)
2021 (4043)
2020 (3467)
2019 (2058)
2018 (1548)
2017 (1793)
2016 (1619)
2015 (1829)
2014 (1367)
2013 (1185)
2012 (1392)
2011 (1328)
2010 (1174)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2051)
Australia (313)
California (2306)
Canada (354)
China (140)
Colorado (82)
Connecticut (26)
Delaware (19)
Europe (4186)
Florida (84)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (36)
India (7)
Indiana (80)
Japan (27)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (86)
Massachusetts (850)
Michigan (15)
Minnesota (35)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (195)
New York (131)
North Carolina (177)
Northern California (1196)
Ohio (68)
Oklahoma (3)
Oregon (7)
Pennsylvania (164)
Puerto Rico (2)
Rhode Island (4)
South America (40)
South Carolina (3)
Southern California (937)
Tennessee (6)
Texas (222)
United States (4649)
Utah (9)
Virginia (17)
Washington D.C. (4)
Washington State (123)
West Virginia (1)
Wisconsin (23)
41,921 Results for "annexon biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annexon to Participate in Upcoming September 2026 Investor Conferences
September 2, 2026
·
1 min read
Press Releases
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2026
October 18, 2026
·
1 min read
Press Releases
Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial
October 28, 2026
·
2 min read
Press Releases
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - September 16, 2026
September 17, 2026
·
1 min read
Press Releases
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - August 17, 2026
August 17, 2026
·
1 min read
Press Releases
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance
July 30, 2026
·
5 min read
Press Releases
Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
August 12, 2026
·
11 min read
Press Releases
Annexon to Participate in Upcoming June 2026 Investor Conferences
May 27, 2026
·
1 min read
Press Releases
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
September 24, 2026
·
6 min read
1 of 4,193
Next
